Adoptive transfer of tumor specific T cells from allogeneic donors is feasible, effective and safe alternative to autologous T cell based tumor immunotherapy. Journal of Medical Science, Poznań, Poland, v. 83, n. 1, p. 21–28, 2014. DOI: 10.20883/medical.e39. Disponível em: https://jmsnew.ump.edu.pl/index.php/JMS/article/view/39. Acesso em: 6 jul. 2025.